Bead-based multiplex genotyping of human papillomaviruses

scientific article

Bead-based multiplex genotyping of human papillomaviruses is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.44.2.504-512.2006
P932PMC publication ID1392679
P698PubMed publication ID16455905

P50authorMichael PawlitaQ37242255
Tim WaterboerQ66386567
Peter J F SnijdersQ90768556
P2093author name stringMarkus Schmitt
Lutz Gissmann
I G Bravo
P2860cites workThe causal relation between human papillomavirus and cervical cancerQ24673148
T-Coffee: A novel method for fast and accurate multiple sequence alignmentQ27860999
Papillomaviruses and cancer: from basic studies to clinical applicationQ29614745
Epidemiologic classification of human papillomavirus types associated with cervical cancerQ29616213
Human papillomavirus is a necessary cause of invasive cervical cancer worldwideQ29617514
POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 womenQ30917882
Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection methodQ33679334
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypesQ33950978
Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirusQ33961947
Improved amplification of genital human papillomavirusesQ33974896
Cancer burden in the year 2000. The global pictureQ34402117
Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causalityQ35154918
Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarraysQ35789859
A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapingsQ36543787
Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worseQ40421829
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.Q43515341
Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteinsQ46650085
Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications of the Luminex LabMAP systemQ50104507
Microsphere suspension array technology for SNP detection in cattleQ51818939
Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics.Q52963160
New cervical cancer screening strategy: combined Pap and HPV testing.Q53359912
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCRQ73108013
Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identificationQ73734970
Suspension arrays for high throughput, multiplexed single nucleotide polymorphism genotypingQ73777223
Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancerQ80373798
P4510describes a project that usesImageQuantQ112270642
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectgenotypingQ912147
P304page(s)504-512
P577publication date2006-02-01
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleBead-based multiplex genotyping of human papillomaviruses
P478volume44

Reverse relations

cites work (P2860)
Q27332306A bead-based multiplex assay for the detection of DNA viruses infecting laboratory rodents
Q64053966A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin
Q43060170A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples
Q86832615A prospective study of positron emission tomography for evaluation of neck node response 6 weeks after radiotherapy in patients with head and neck squamous cell carcinoma
Q100634459ATP synthase modulation leads to an increase of spare respiratory capacity in HPV associated cancers
Q33614132Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay
Q37263655Adhesion of human and animal Escherichia coli strains in association with their virulence-associated genes and phylogenetic origins
Q33330059Advances in multiple analyte profiling.
Q90629815An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway
Q93125739Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay
Q38859268Antibody response for L1, E6 and E7 HPV 16 and HPV 18 antigens in Tunisian women with cervical cancer and controls
Q38859265Antibody response for L1, E6, E7 HPV 16, and HPV 18 antigens in Tunisian women with cervical cancer
Q43308250Are human papillomavirus DNA prevalences providing high-flying estimates of infection? An international survey of HPV detection on environmental surfaces
Q34806026Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease.
Q35691927Association Study between Cervical Lesions and Single or Multiple Vaccine-Target and Non-Vaccine Target Human Papillomavirus (HPV) Types in Women from Northeastern Brazil
Q37838503Asymptomatic anal sexually transmitted infections in HIV-positive men attending anal cancer screening
Q35273769Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types.
Q40175186Bead-based suspension array for simultaneous differential detection of five major swine viruses
Q92090103Benign proliferative epithelial lesions of oral mucosa are infrequently associated with α-, β-, or γ human papillomaviruses
Q55279812Beta and gamma human papillomaviruses in anal and genital sites among men: prevalence and determinants.
Q53081710Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers.
Q37003406Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma.
Q36295974Biomarkers of HPV in head and neck squamous cell carcinoma.
Q40873298CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma
Q35985028Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin
Q35984742Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma
Q36813303Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
Q64069837Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine
Q36584383Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update
Q37582845Characterization of human papillomavirus type 154 and tissue tropism of gammapapillomaviruses
Q48134092Cigarette Smoking Promotes Infection of Cervical Cells by High-Risk Human Papillomaviruses, but not Subsequent E7 Oncoprotein Expression
Q94585060Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
Q37643509Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region
Q37800921Commercially available assays for multiplex detection of alpha human papillomaviruses
Q41027688Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
Q37546224Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping
Q36413963Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.
Q42246317Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma
Q40122573Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study
Q38674506Concordance of HPV load and HPV mRNA for 16 carcinogenic/possibly carcinogenic HPV types in paired smear/tissue cervical cancer specimens.
Q93233995Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma
Q84155467Creation and characterization of a xenograft model for human cervical cancer
Q30276138Cutaneous beta human papillomaviruses and the development of male external genital lesions: A case-control study nested within the HIM Study
Q30409315Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study
Q27693832Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?
Q57148320Cutaneous viral infections across two anatomic sites among a cohort of skin cancer screening patients
Q35689066Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study
Q34212228Detection of human papillomaviruses by polymerase chain reaction and ligation reaction on universal microarray
Q38658091Detection of oncogenic viruses in water environments by a Luminex-based multiplex platform for high throughput screening of infectious agents
Q37116707Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses
Q34185819Development of a bead-based multiplex genotyping method for diagnostic characterization of HPV infection
Q39882377Development of a multiplexed bead-based assay for detection of DNA methylation in cancer-related genes
Q35193233Development of a novel liquid bead array human papillomavirus genotyping assay (PGMY-LX) and comparison with linear array for continuity in longitudinal cohort studies
Q27485492Diagnostic Evaluation of Multiplexed Reverse Transcription-PCR Microsphere Array Assay for Detection of Foot-and-Mouth and Look-Alike Disease Viruses
Q40280339Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Q64061838Distribution of high-risk HPV types among women in Sichuan province, China: a cross-sectional study
Q40681570Diversity of beta-papillomavirus at anogenital and oral anatomic sites of men: The HIM Study.
Q42256779Diversity of human papillomaviruses in skin lesions
Q41864212Dramatic increase in the signal and sensitivity of detection via self-assembly of branched DNA
Q38959371Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents
Q53519290Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma.
Q37628138Emerging molecular assays for detection and characterization of respiratory viruses
Q38944279Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice
Q51553909Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods
Q35083596Evaluation of a novel Chlamydia trachomatis microsphere suspension assay for detection and genotyping of the different serovars in clinical samples
Q35192200Evaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts.
Q37348338Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma
Q34782761Expressed prostate secretions in the study of human papillomavirus epidemiology in the male
Q34472748Expression of the p53 target Wig-1 is associated with HPV status and patient survival in cervical carcinoma
Q38879048Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
Q40651861FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
Q37845965False-positive prostate cancer markers in a man with symptomatic urethral Chlamydia trachomatis infection
Q34411111Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2)
Q51490957Flow field induced particle accumulation inside droplets in rectangular channels.
Q40500436Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable
Q35267714Food microbial pathogen detection and analysis using DNA microarray technologies
Q40172590Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study
Q34046478Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study
Q34542473Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study
Q38874178Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer
Q40892448German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment
Q34489632Global Proficiency Study of Human Papillomavirus Genotyping
Q37546177Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study
Q59330336Gynecologic assessment of 19 adult females with cartilage-hair hypoplasia - high rate of HPV positivity
Q36238070HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization.
Q36088064HPV detection methods in head and neck cancer
Q34345540HPV genotyping and site of viral integration in cervical cancers in Indian women
Q51653476HPV infection among women in a representative rural and suburban population of the USA.
Q42377376HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?
Q58574765HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV
Q35133590Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome
Q34493325High expression of ezrin predicts poor prognosis in uterine cervical cancer
Q38800101High prevalence of human papillomaviruses in Ghanaian pregnant women
Q44794336High-risk human papillomavirus associated with incident cervical intraepithelial neoplasia developing in mothers in the Finnish Family HPV Study cohort
Q34806867High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients
Q36381319High-throughput SNP-based authentication of human cell lines
Q37393485High-throughput detection and multiplex identification of cell contaminations
Q35101247Highly Sensitive Detection and Genotyping of HPV by PCR Multiplex and Luminex Technology in a Cohort of Colombian Women with Abnormal Cytology
Q36497937Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers
Q36197117Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings
Q36418117Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013.
Q37923517Human papilloma virus (HPV) molecular diagnostics.
Q41579102Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes
Q47260023Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence
Q39145678Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study
Q42217974Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy
Q47790765Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study.
Q33778119Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review).
Q37703394Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome
Q45084618Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study
Q35232819Human papillomavirus and tonsillar and base of tongue cancer
Q40214883Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.
Q42276676Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials
Q51426652Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males.
Q92585076Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status
Q42244723Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India
Q28286766Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor
Q43777296Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study
Q92462451Human papillomavirus is not associated to non-small cell lung cancer: data from a prospective cross-sectional study
Q47599112Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts.
Q40292220Human papillomavirus prevalence in mouthwashes of patients undergoing tonsillectomy shows dominance of HPV69, without the corresponding finding in the tonsils
Q36706422Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma
Q35050431Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women
Q64262922Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention
Q37650660Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina
Q42274810Human papillomavirus-associated balanoposthitis--a marker for penile intraepithelial neoplasia?
Q34544410Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma
Q58813676Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway
Q33940157Incident cervical infections with high- and low-risk human papillomavirus (HPV) infections among mothers in the prospective Finnish Family HPV Study
Q45942793Increasing hybridization rate and sensitivity of bead-based assays using isotachophoresis.
Q43564259Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.
Q34600215Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis
Q33682928Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
Q38739835Isolation and characterization of a novel putative human polyomavirus
Q40258689Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer
Q36755552LUMINEX®: a new technology for the simultaneous identification of five Entamoeba spp. commonly found in human stools
Q36414507Lack of methylation in the upstream region of human papillomavirus type 6 from aerodigestive tract papillomas
Q42204957Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.
Q38867836Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma
Q47599117Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy
Q36281407Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines.
Q42200739Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
Q37116753Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus
Q39120200Molecular approaches for HPV genotyping and HPV-DNA physical status
Q33428795Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen
Q39400513Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas.
Q39725202Multiplatform comparison of multiplexed bead arrays using HPV genotyping as a test case.
Q36826745Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities
Q41689179Multiplex PCR assay for the rapid identification of human papillomavirus genotypes 16, 18, 45, 35, 66, 33, 51, 58, and 31 in clinical samples.
Q54305915Multiplex analysis of tumor multidrug-resistance genes expression with photonic suspension array.
Q36398321Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension array.
Q88113305Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
Q34447373Natural history of polyomaviruses in men: the HPV infection in men (HIM) study.
Q45338163Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
Q42263135No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors
Q59353927Novel cytomorphologic characteristics suggesting human papillomavirus infection in patients diagnosed as negative for intraepithelial lesion or malignancy and a comparison of diagnostic performance of three human papillomavirus tests
Q35689082Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types
Q54335305Novel multiplexed genotyping of human papillomavirus using a VeraCode-allele-specific primer extension method.
Q38826857Oral health and human papillomavirus-associated head and neck squamous cell carcinoma
Q42275766Oral human papillomavirus prevalence in high school students of one municipality in Sweden.
Q35804927Oropharyngeal Cancer Epidemic and Human Papillomavirus
Q42204969Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer
Q43691500Penile intraepithelial neoplasia: histopathological evaluation, HPV typing, clinical presentation and treatment.
Q43117756Peptide nucleic acid-based array for detecting and genotyping human papillomaviruses
Q41744901Peripheral and local human papillomavirus 16-specific CD8+ T-cell expansions characterize erosive oral lichen planus.
Q51580698Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types.
Q54946451Polyomaviruses detectable in head and neck carcinomas.
Q41119047Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland
Q34916951Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
Q35498040Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities
Q40847705Presence of human papillomavirus in semen in relation to semen quality
Q44817366Presence of human papillomaviruses and p16 expression in hypopharyngeal cancer
Q36253884Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy.
Q33629489Prevalence and Transmission of Beta and Gamma Human Papillomavirus in Heterosexual Couples
Q41206464Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India
Q58585929Prevalence and correlates of beta and gamma human papillomavirus detection in oral samples from mid-adult women
Q55082939Prevalence and correlates of beta human papillomavirus detection in fingernail samples from mid-adult women.
Q54289295Prevalence and viral load of 51 genital human papillomavirus types and three subtypes.
Q39841008Prevalence of BPV genotypes in a German cowshed determined by a novel multiplex BPV genotyping assay
Q38673356Prevalence of cutaneous beta and gamma human papillomaviruses in the anal canal of men who have sex with women.
Q34450371Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour
Q51023169Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.
Q92579765Prevalence of human papillomavirus and Helicobacter pylori in esophageal and gastroesophageal junction cancer biopsies from a case-control study in Ethiopia
Q44457555Prevalence of human papillomavirus types in cervical and oral cancers in central India
Q52585506Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer.
Q36221266Prevalence of oral human papillomavirus infection among youth, Sweden
Q34640608Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors
Q34404710Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study
Q34518220Previous tonsillectomy modifies odds of tonsil and base of tongue cancer
Q37154221Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts
Q33854472Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma
Q31149498Quantitative data analysis methods for bead-based DNA hybridization assays using generic flow cytometry platforms.
Q53071357Radiotherapy response in head and neck cancer - evaluation of the primary tumour site.
Q35066941Rapid genotyping of human papillomavirus by post-PCR array-based hybridization techniques
Q35847330Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories
Q40289265Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma
Q42270386Smoking increases oral HPV persistence among men: 7-year follow-up study
Q42238481Stable marital relationship protects men from oral and genital HPV infections
Q87423605Submaxillary gland androgen-regulated protein 3A expression is an unfavorable risk factor for the survival of oropharyngeal squamous cell carcinoma patients after surgery
Q90238817Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway
Q61444373TaME-seq: An efficient sequencing approach for characterisation of HPV genomic variability and chromosomal integration
Q36118729The 2010 global proficiency study of human papillomavirus genotyping in vaccinology
Q33702362The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma
Q40349414The male ScreenING Study: prevalence of HPV-related genital and anal lesions in an urban cohort of HIV-positive men in Germany
Q40291505The prevalence of HPV infections in HPV-vaccinated women from the general population.
Q92445348The use of molecular markers for cervical screening of women living with HIV in South Africa
Q33517490Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples
Q37352574Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
Q38133612Understanding HPV tests and their appropriate applications
Q47748258Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma.
Q36513003Using oligonucleotide suspension arrays for laboratory identification of bacteria responsible for bacteremia
Q35113813Validation of a diagnostic microarray for human papillomavirus: coverage of 102 genotypes
Q37360505Validation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples
Q36852263Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
Q41020481Viral infections in prostate carcinomas in Chilean patients
Q41203108Viral load and mRNA expression of HPV type 6 among cases with recurrent respiratory papillomatosis
Q40070529Viruses in cancers among the immunosuppressed.
Q38967902p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region
Q40767169p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population